Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aecon announces voting results of Annual General Meeting
-
OceanFirst Financial Corp. Completes Merger with Flushing Financial Corporation and $225 Million Strategic Investment from Warburg Pincus
-
EQiLeaders, Inc. Announces Expanded Executive Career Coaching and Strategic Positioning Services for Professionals Seeking Career Advancement
-
Fairfax Announces Quarterly Dividend on Series K Preferred Shares
-
PrairieSky Receives TSX Approval for Renewed Normal Course Issuer Bid
-
Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update
-
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
-
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
embecta to Participate in Investor Events
-
Gencor Announces Receipt of NYSE Regulation Notice Regarding Late Filing of the Quarterly Report on Form 10-Q for the period Ended March 31, 2026
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
HII’s Ingalls Shipbuilding Celebrates 2026 Class of Master Shipbuilders
-
Brookfield Office Properties Announces Reset Dividend Rates and Conversion Privileges on its Class AAA Series N Preference Shares
-
Total Voting Rights
-
CTO Realty Growth Announces the Sale of an Atlanta Asset for $73.3 Million
-
Guggenheim Investments Announces June 2026 Closed-End Fund Distributions
-
University of Miami Miller School of Medicine Names Dr. Pradeep Ramulu Chair of Ophthalmology and the Bascom Palmer Eye Institute
-
Xometry Announces Proposed Public Offering of Class A Common Stock
-
Hallador Energy Acquires 460 MW of Siemens Turbines for $350 Million, Accelerating Merom Natural Gas Generation Project
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
USCB Financial Holdings, Inc. Names Sergio Garrido Chief Credit Officer; Announces Retirement of William “Bill” Turner
-
Weatherford Details Value-Driven Case for Redomestication, Encourages Shareholders to Vote FOR Proposal
-
General Fusion to Participate in June Investor and Industry Conferences
-
USA Rare Earth to Present at the William Blair 46th Annual Growth Stock Conference
-
authID Announces its 2026 Annual Meeting to be Held on July 6, 2026
-
The RoyaLand Company Ltd. Announces Closing of the Acquisition of 90% Stake in Storied Italian Football Club Savoia 1908
-
CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
-
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Teva to Present at the Goldman Sachs Global Healthcare Conference
-
Thomas Global Systems Completes Supplier Qualification Testing of Crew Station Components for AH-64E Apache, Delivers Units For Boeing Testing
-
Steelworkers secure historic gains in new Vale agreement
-
Le Vian® Reveals the Five Jewelry Trends Defining 2027 at JCK Las Vegas
-
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
-
Microchip Provides Data Center Solutions Business Unit Revenue Information
-
Embassy Bancorp, Inc. Announces Expansion of its Stock Repurchase Program
-
California Water Service Earns G480 Platinum Certification for Water-Use Efficiency, Conservation Program
-
Praxis Precision Medicines Provides Vormatrigine Program Update
-
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share
-
Microchip Technology to Present at the B of A Securities Global Technology Conference 2026
-
Microchip Technology Appoints Mitch Little to Its Board of Directors
-
LXP Industrial Trust Provides Recent Business Activity Update and Increases 2026 Adjusted Company FFO Guidance
-
JM Group Limited Provides Further Update Regarding Trading Halt of its Securities
-
UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
Dave & Buster’s Entertainment, Inc. to Report First Quarter 2026 Financial Results on June 15, 2026
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Broadcom Connects the AI Edge with Comprehensive Multi-Gig Broadband and Wi-Fi 8 Innovations
-
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
-
Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role
-
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
-
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
